<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baranwal</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chiranjivi</surname>
    <given-names>A. K.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dubey</surname>
    <given-names>V. K.</given-names>
   </name>
   <name>
    <surname>Chandra</surname>
    <given-names>P.</given-names>
   </name>
  </person-group> (
  <year>2018</year>). 
  <article-title>Design of Commercially Comparable Nanotherapeutic Agent against Human Disease-Causing Parasite, Leishmania</article-title>. 
  <source>Sci. Rep.</source>
  <volume>8</volume>. 
  <fpage>8814</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41598-018-27170-1</pub-id>
  <pub-id pub-id-type="pmid">29891923</pub-id>
 </mixed-citation>
</ref>
